Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells 919,389 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 919,389 shares of the stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $8.00, for a total transaction of $7,355,112.00. Following the transaction, the insider directly owned 12,531,158 shares of the company’s stock, valued at approximately $100,249,264. This trade represents a 6.84% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Wednesday, June 3rd, J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock. The shares were sold at an average price of $6.24, for a total transaction of $36,455,577.60.

Aveanna Healthcare Trading Up 1.5%

Shares of AVAH stock traded up $0.12 during trading hours on Friday, hitting $8.61. The company had a trading volume of 953,109 shares, compared to its average volume of 1,436,922. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47. The stock has a market capitalization of $1.87 billion, a PE ratio of 7.29, a price-to-earnings-growth ratio of 0.87 and a beta of 1.93. The company’s fifty day moving average is $7.10 and its 200 day moving average is $7.57. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $3.73 and a fifty-two week high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The firm had revenue of $647.91 million during the quarter, compared to the consensus estimate of $613.22 million. The company’s revenue for the quarter was up 15.9% compared to the same quarter last year. Research analysts expect that Aveanna Healthcare Holdings Inc. will post 0.65 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Royal Bank Of Canada raised Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price on the stock in a research note on Wednesday, June 3rd. BMO Capital Markets reduced their price target on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, March 20th. Weiss Ratings cut shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, April 6th. Raymond James Financial upgraded shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 target price on the stock in a report on Friday, March 20th. Finally, Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $10.00 to $11.00 in a research note on Friday, May 15th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $10.50.

Institutional Trading of Aveanna Healthcare

Hedge funds have recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd lifted its stake in Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after acquiring an additional 2,400 shares during the last quarter. Quantbot Technologies LP purchased a new stake in shares of Aveanna Healthcare in the 2nd quarter valued at approximately $43,000. Summit Securities Group LLC acquired a new stake in shares of Aveanna Healthcare in the 1st quarter valued at $53,000. Oxford Asset Management LLP acquired a new stake in shares of Aveanna Healthcare in the 2nd quarter valued at $64,000. Finally, Bayesian Capital Management LP purchased a new stake in shares of Aveanna Healthcare during the 2nd quarter worth $85,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.